Medicare Enrolled
Dr. Dana Kang, MD
Optician · Arcadia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kang
Dr. Dana Kang is an optician specialist in Arcadia, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kang performed 3,204 Medicare services across 1,579 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kang received a total of $8,293 from 39 pharmaceutical and/or device companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 26% volume in CA
$8,293 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,204
Medicare services
Top 26% in CA for optician
1,579
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~178 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,054 | $6 | $16 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
375 | $68 | $200 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
368 | $91 | $265 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
297 | $92 | $281 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
257 | $41 | $153 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
166 | $71 | $236 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
110 | $43 | $126 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
100 | $136 | $388 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
69 | $81 | $247 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $118 | $365 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
51 | $1 | $2 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
48 | $51 | $161 |
| Destruction of skin growth, 15 or more growths | 43 | $102 | $307 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
40 | $42 | $116 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
40 | $102 | $292 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
36 | $253 | $699 |
| Light application with debridement to destroy precancerous skin growth This procedure involves applying light to the skin along with debridement to destroy precancerous skin growths. |
30 | $261 | $666 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
19 | $110 | $559 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
18 | $43 | $131 |
| Topical aminolevulinic acid HCl 20% solution A topical medication applied to the skin for medical treatment. It is supplied as a single-unit dosage form containing 354 mg of the active ingredient. |
17 | $307 | $782 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,293
Total received (2018-2024)
Avg $1,185/year across 7 years
Top 16% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
370
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,293 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,344
2023
$2,022
2022
$1,261
2021
$893
2020
$251
2019
$698
2018
$823
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$522
ABBVIE INC.
$372
Incyte Corporation
$307
Janssen Biotech, Inc.
$213
LEO Pharma Inc.
$184
Regeneron Healthcare Solutions, Inc.
$168
SUN PHARMACEUTICAL INDUSTRIES INC.
$118
PFIZER INC.
$116
Lilly USA, LLC
$83
Novartis Pharmaceuticals Corporation
$71
REVANCE THERAPEUTICS, INC.
$49
Arcutis Biotherapeutics, Inc.
$34
Amgen Inc.
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
Almirall LLC
$23
Helsinn Therapeutics (U.S.), Inc.
$18
MAYNE PHARMA COMMERCIAL LLC
$15
Top 3 companies account for 51.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$915
GENZYME CORPORATION
$834
Incyte Corporation
$756
Regeneron Healthcare Solutions, Inc.
$708
LEO Pharma Inc.
$664
PFIZER INC.
$496
Janssen Biotech, Inc.
$429
Lilly USA, LLC
$392
Ortho Dermatologics, a division of Bausch Health US, LLC
$338
AbbVie Inc.
$331
Sun Pharmaceutical Industries Inc.
$293
Galderma Laboratories, L.P.
$242
Almirall LLC
$241
SUN PHARMACEUTICAL INDUSTRIES INC.
$176
E.R. Squibb & Sons, L.L.C.
$150
Biofrontera Inc.
$144
AbbVie, Inc.
$128
Taro Pharmaceuticals USA, Inc.
$106
Arcutis Biotherapeutics, Inc.
$104
EPI Health, LLC
$102
Novartis Pharmaceuticals Corporation
$101
Stemline Therapeutics Inc.
$83
Amgen Inc.
$72
MAYNE PHARMA COMMERCIAL LLC
$52
REVANCE THERAPEUTICS, INC.
$49
PruGen, Inc. Pharmaceuticals
$42
Aclaris Therapeutics, Inc.
$35
Allergan, Inc.
$33
Mayne Pharma Inc.
$32
Helsinn Therapeutics (U.S.), Inc.
$32
Fresenius Kabi USA, LLC
$31
STRATA Skin Sciences, Inc.
$28
UCB, Inc.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
TARO PHARMACEUTICALS USA, INC.
$24
Celgene Corporation
$24
Genentech USA, Inc.
$18
Mission Pharmacal Company
$17
Journey Medical Corporation
$16
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA LD · ADBRY · AKLIEF · AMELUZ · ARAZLO · Ameluz · Avar · BLU-U · BOTOX COSMETIC · BRYHALI · CIBINQO · CLODERM · COSENTYX · Cimzia · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dermatological Psoriasis and Vitiligo Treatment · ELZONRIS · ENSTILAR · EPIDUO FORTE · EUCRISA · Erivedge · HALOG (Halcinonide Cream · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · IDACIO · ILUMYA · Ilumya · Klisyri · LIBTAYO · LITFULO · OPZELURA · ORACEA · Odomzo · Otezla · REMICADE · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · ULTRAVATE · ULTRAVATE (halobetasol propionate) lotion · USP) 0.1% · VALCHLOR · Veltin · Winlevi · XTRAC · Xolegel · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
1,331
Per 100K population
13.5
County median income
$87,760
Nearest hospital
USC ARCADIA HOSPITAL
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kang is a clinical cardiology specialist, with above-average Medicare volume (top 26% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kang experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Kang performed 1,054 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kang receive payments from pharmaceutical companies?
Yes. Dr. Kang received a total of $8,293 from 39 companies across 370 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kang's costs compare to other opticians in Arcadia?
Dr. Kang's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Arcadia
Browse opticians in Arcadia ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology